Naslov
Botulin toxin A in lower lid entropium correction

Autori
Ninčević, Ana ; Kalauz, Miro ; Knežević, Josip ; Masnec, Sanja

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Liječnički Vjesnik 144(Supl. 2) / - , 2022, 85-85

Skup
17th Croatian Student Summit Sensing the World: Otorhinolaryngology & Ophthalmology (CROSS17)

Mjesto i datum
Zagreb, Hrvatska, 27.04.2022. - 30.04.2022

Vrsta sudjelovanja
Poster

Vrsta recenzije
Nije recenziran

Ključne riječi
botulinum toxin, senile entropion, treatment

Sažetak
INTRODUCTION/OBJECTIVES: to evaluate the clinical results and report the results of 12 cases of senile involutional entropion of the lower lid treated with botulinum toxin MATERIALS AND METHODS: Twelve patients with senile entropion were treated with an injection of botulinum toxin. The mean age was 67, 2±7, 3. The toxin (Botox ; Allergan Corporation, Irvine, CA) was supplied in a vial contained 100 units of freeze-dried botulinum toxin A. This was reconstituted and diluted with 2 ml of saline which resulted with a concentration of five units in 0.1. The reconstituted toxin was injected over the orbicularis oculi muscle subcutaneously 4 mm below the eyelash margin of lower eyelid at three sites with a 30-gauge needle. Five units of the toxin were injected in each site (15 units total). The patients were examined 7 days after the aplication, 30 days and then monthly up to 1 year. RESULTS: In all treated patients improvement of the eyelid margin was visible within three to four days after the injection with the duration which varied from 8 to 16 weeks. No complications or side effects of the treatment was recorded. CONCLUSION: Botulinum toxin A can be effective temporary treatment for senile lower lid entropion.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

POVEZANOST RADA